Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia

NCT04248010 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04248010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04248010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2022
Completion date
June 1, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia and related disorders